KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$71.0 million.

  • Bristol Myers Squibb's Change in Inventory rose 5942.86% to -$71.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $184.0 million, marking a year-over-year decrease of 6213.99%. This contributed to the annual value of $184.0 million for FY2025, which is 6213.99% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Change in Inventory is -$71.0 million, which was up 5942.86% from $90.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Change in Inventory high stood at $282.0 million for Q1 2023, and its period low was -$175.0 million during Q4 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Change in Inventory value was $28.5 million (recorded in 2022), while the average stood at $73.8 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Change in Inventory soared by 2830000.0% in 2023, and later tumbled by 18883.25% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Change in Inventory (Quarter) stood at $128.0 million in 2021, then crashed by 67.97% to $41.0 million in 2022, then surged by 380.49% to $197.0 million in 2023, then crashed by 188.83% to -$175.0 million in 2024, then surged by 59.43% to -$71.0 million in 2025.
  • Its Change in Inventory was -$71.0 million in Q4 2025, compared to $90.0 million in Q3 2025 and -$4.0 million in Q2 2025.